Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors

Garayoa, M, Garcia, J L, Santamaria, C, Garcia-Gomez, A, Blanco, J F, Pandiella, A, Hernández, J M, Sanchez-Guijo, F M, del Cañizo, M-C, Gutiérrez, N C, San Miguel, J F·2009·Leukemia
DOI 10.1038/leu.2009.65

Cited by (152)

Items 101–152 of 152

  1. Stable Changes in Mesenchymal Stromal Cells from Multiple Myeloma Patients Revealed through Their Responses to Toll-Like Receptor Ligands and Epidermal Growth Factor
    Meirav Pevsner‐Fischer, Sarit Levin, Tal Hammer-Topaz, Yifat Cohen, Felix Mor, Gerard Wagemaker, Arnon Nagler, Irun R. Cohen, Dov Zipori · 2011 · Stem Cell Reviews and Reports
  2. Anti-cancer effects of Staphylococcal Enterotoxin type B on U266 cells co-cultured with Mesenchymal Stem Cells
    Mostafa Ejtehadifar, Raheleh Halabian, Abbas Ali Imani Fooladi, Ali Ghazavi, Ghasem Mosayebi · 2017 · Microbial Pathogenesis
  3. Elevation of miR-302b prevents multiple myeloma cell growth and bone destruction by blocking DKK1 secretion
    Zheyu Wu, Yufeng Zhang, Zhiqiang Yang, Yufan Zhu, Yuanlong Xie, Fuling Zhou, Lin Cai · 2021 · Cancer Cell International
  4. Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma
    Nicolas Thomas Iannozzi, Valentina Marchica, Denise Toscani, Jessica Burroughs-Garcìa, Nicola Giuliani, Paola Storti · 2022 · International Journal of Molecular Sciences
  5. Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients
    Nicola Giuliani, Gina Lisignoli, Francesca Novara, Paola Storti, Nadia Zaffaroni, Raffaella Villa, Gabriella Sammarelli, Luca Agnelli, Katia Todoerti, Maria Ester Bernardo et al. · 2010 · Leukemia
  6. Production of Clinical Grade Mesenchymal Stromal Cells
    Pytlik, Slanar, Stehlik, Matejkov · 2011 · InTech eBooks
  7. Emerging Therapeutic Targets for Metabolic Syndrome: Lessons from Animal Models
    Himadri Singh, Samuel Joshua Pragasam, Vijayalakshmi Venkatesan · 2018 · Endocrine Metabolic & Immune Disorders - Drug Targets
  8. Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
    Rodrigo Carlini Fernando, Fabrício de Carvalho, Adriana Franco Paes Leme, Gisele W. B. Colleoni · 2021 · Frontiers in Oncology
  9. Mesenchymal Stem Cells Inhibit the Effects of Dexamethasone in Multiple Myeloma Cells
    Mingyang Deng, Huan Yuan, Hongling Peng, Sufang Liu, Xiang Xiao, Zhihua Wang, Guangsen Zhang, Han Xiao · 2022 · Stem Cells International
  10. Microambiente medular en la leucemia mieloide crónica: su relación con la enfermedad y la respuesta al tratamiento
    José Alejandro Aristizábal, Mauricio Chandía, María Consuelo del Cañizo, Fermin M. Sanchez-Guijo · 2014 · Revista médica de Chile
  11. Extracellular vesicles in multiple myeloma-bone marrow niche crosstalk: from cellular dialogue to clinical perspectives
    Martina Forestiero, Anna Maria Zimbo, Giulia Gentile, Marianna Puzzo, Rocco Malivindi, Enrica Antonia Martino, Ernesto Vigna, Massimo Gentile, Daniela Bonofiglio, Luca Gelsomino et al. · 2025 · Journal of Translational Medicine
  12. Current Understanding of Myelomatous Mesenchymal Stromal Cells Extended through Advances in Experimental Methods
    Michiko Ichii, Naoki Hosen · 2020 · Cancers
  13. Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH
    Joanne S. White, Adrian Zordan, Crisoula Batzios, Lynda J. Campbell · 2012 · Cancer Genetics
  14. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
    Xinxin Xu, Yang Jiao, Yu Tang, Junxia Li, Yan Ming Zhu, Hua Lu, Xiaoming Fei · 2014 · PubMed Central
  15. Phenotypic and functional alterations of bone marrow MSCs exposed to multiple myeloma cells
    Hye Joung Kim, So Young Eom, Saeyeon Hwang, Hyunsoo Kim, Jihee Won, Seok Hwan Chung, Seung‐Ah Yahng · 2023 · Molecular & Cellular Toxicology
  16. Capacity Dimensioning for Wireless Communications System
    Xinsheng Zhao, Hao Liang · 2010 · InTech eBooks
  17. Organ bioengineering for the newborn
    Panagiotis Maghsoudlou, Luca Urbani, Paolo De Coppi · 2014 · Seminars in Pediatric Surgery
  18. Chromosomal abnormalities of mesenchymal stromal cells in hematological malignancies
    Mateus de Oliveira Lisboa, Tamara Borgonovo, Letícia Fracaro, Aline Rangel Pozzo, Paulo Roberto Slud Brofman, Sabine Mai · 2025 · Oncogene
  19. Molecular Aberrations in Bone Marrow Stromal Cells in Multiple Myeloma
    Olga Blau, Rimma Berenstein, Marlies Wächter, Axel Nogai, Aline Künel, Mirgul Bayanova, Igor Wolfgang Blau · 2019 · IntechOpen eBooks
  20. Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells
    Almudena Navarro‐Bailón, Miriam López-Parra, Álvaro Veiga Vaz, Eva M. Villarón, María Díez‐Campelo, Ana África Martín, Estefanía Pérez‐López, Mónica Cabrero, Lourdes Vázquez, Lucía López‐Corral et al. · 2024 · Cytotherapy
  21. The Pathophysiology of Myeloma Bone Disease: Role of Osteoblasts and Osteocytes
    Nicola Giuliani, Federica Costa, Valentina Marchica · 2021 · Springer eBooks
  22. PreclinicalActivityoftheOralProteasomeInhibitorMLN9708 in Myeloma Bone Disease
    Allison Berger, Carlos Ortíz-de-Solórzano, Teresa Hernández‐Iglesias, Joaquín Mateo-Urdiales, Susana Fraile, Miguel Galarraga, Dharminder Chauhan, Jesús F. San Miguel, Noopur S Raje, Mercedes Garayoa · 2014
  23. Cytogenetic changes of mesenchymal stem cells in the neoplastic bone marrow niche in leukemia
    Shirin Ferdowsi, Shirin Azizidoost, Ghafari Nasim, Najmaldin Saki · 2016 · Frontiers in Biology
  24. Gene Expression Profiles of Bone Marrow Stromal Cells and Their Correlation with Clinical Characteristics of Patients with Multiple Myeloma
    김선영 · 2013
  25. Proteasome Inhibitors with a Focus on Bortezomib
    Kevin M. Barley, Samir Sunil Parekh · 2018 · Resistance to targeted anti-cancer therapeutics
  26. Genomic instability in Multiple Myeloma-relevance for Clinical Outcome and Efficacy of Therapy
    Fumou Sun, Yan Cheng, Siegfried Janz · 2019 · Blood and Genomics
  27. Biologic profile evaluation of mesenchymal stem cells in co-culture with K562 cells
    Najmaldin Saki, Niloofar Farshchi, Saeed Azandeh, Mohammad Taha Jalali · 2020 · Clinical Cancer Investigation Journal
  28. Impact of MGUS and myeloma on skeletal health
    G. David Roodman, Matthew T. Drake · 2020 · Elsevier eBooks
  29. Tissue-specific Stem Cells
    Sudhansu Shekhar Patra · 2020
  30. Células Stem mesenquimales en el transplante alogénico de progenitores hematopoyéticos: análisis de la experiencia clínica de la unidad de producción celular del Complejo Asistencial Universitario de Salamanca
    Álvaro Veiga Vaz · 2020
  31. Non-Hierarchically Organized Operations in Malignancies: Stromal Dysfunction Induces and Maintains Hematopoietic Malignancies
    Jochen Grassinger, Roland Christian Schelker · 2013 · Springer eBooks
  32. Supplementary Data-Data from Amiloride, An Old Diuretic Drug, Is a Potential Therapeutic Agent for Multiple Myeloma
    Elizabeta A. Rojas, Luis Antonio Corchete, Laura San‐Segundo, Juan Francisco Martínez-Blanch, Francisco M. Codoñer, Teresa Paíno, Noemí Puig, Ramón García‐Sánz, María‐Victoria Mateos, Enrique M. Ocio et al. · 2023
  33. Supplementary Data-Data from Amiloride, An Old Diuretic Drug, Is a Potential Therapeutic Agent for Multiple Myeloma
    Elizabeta A. Rojas, Luis Antonio Corchete, Laura San‐Segundo, Juan Francisco Martínez-Blanch, Francisco M. Codoñer, Teresa Paíno, Noemí Puig, Ramón García‐Sánz, María‐Victoria Mateos, Enrique M. Ocio et al. · 2023
  34. Osteogenic differentiation potential by mouse bone marrow-derived mesenchymal stemcells (mbm-mscs) derived from gut leak-induced diabetes type ii mouse model
    Nabila Syarifah Jamilah · 2020 · Chula Digiverse
  35. Rôle du système IGF-1/insuline dans le Myélome Multiple
    Anne Catherine Sprynski · 2009 · HAL
  36. Additional file 2 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  37. Additional file 2 of Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
    Lu, Yu, Zheng, Chaohui, Wenxia Zhang, Xuan Liu, Zhou, Ziwei, Zhenzhen Wang, Huan Hua, Zhengrong Song, Zhang, Xuejun, Liu, Shuyi et al. · 2024 · Figshare
  38. Additional file 1 of Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
    Lu, Yu, Zheng, Chaohui, Wenxia Zhang, Xuan Liu, Zhou, Ziwei, Zhenzhen Wang, Huan Hua, Zhengrong Song, Zhang, Xuejun, Liu, Shuyi et al. · 2024 · Figshare
  39. Additional file 6 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  40. Additional file 3 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  41. Additional file 5 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  42. Additional file 4 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  43. Additional file 8 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  44. Additional file 1 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  45. Additional file 4 of Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
    Lu, Yu, Zheng, Chaohui, Wenxia Zhang, Xuan Liu, Zhou, Ziwei, Wang, Zhenzhen, Huan Hua, Zhengrong Song, Zhang, Xuejun, Liu, Shuyi et al. · 2024 · Figshare
  46. Additional file 9 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  47. Additional file 3 of Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
    Lu, Yu, Zheng, Chaohui, Wenxia Zhang, Xuan Liu, Zhou, Ziwei, Zhenzhen Wang, Huan Hua, Zhengrong Song, Zhang, Xuejun, Liu, Shuyi et al. · 2024 · Figshare
  48. Additional file 7 of ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
    Zhang, Dan, Kim De Veirman, Fan, Rong, Jian, Qiang, Zhang, Yuchen, Lei, Li, Holly Evans, Wang, Yanmeng, Lei, Lei, Wang, Baiyan et al. · 2020 · Figshare
  49. Bone marrow mesenchymal stromal cells and multiple myeloma: Cellular interactions and therapeutic opportunities
    Aishwarya Dash, Man Updesh Singh Sachdeva, Nabhajit Mallik, Sreejesh Sreedharanunni, Manni Luthra‐Guptasarma, Pankaj Malhotra · 2026 · Pathology - Research and Practice
  50. Caractérisations phénotypiques et fonctionnelles des cellules stromales mésenchymateuses au cours du traitement du myélome multiple
    Lea Lemaitre · 2020 · theses.fr (ABES)
  51. Enhanced sialylation of bone marrow mesenchymal stromal cells contributes to immune remodeling through macrophage polarization in multiple myeloma patients
    Achille Ruer, David Van Morckhoven, Karlien Pieters, Nathalie Meuleman, Laurence Lagneaux, Basile Stamatopoulos · 2026 · Frontiers in Immunology
  52. A 3D engineered multiple myeloma niche for evaluating CAR T cell therapy
    Lorea Jordana-Urriza, Manuele Giuseppe Muraro, Marc Du, Victoria Lambrecht, Juan R. Rodríguez-Madoz, Iván Martín, Andrés García‐García · 2026 · Frontiers in Bioengineering and Biotechnology